Investor Presentaiton

Market cap at IPO USD 80mm Milestones of Innovation FB825 Exclusive licensing agreement with LEO Pharma Fespixon Fespixon market expansion 2022 US$40M + up to US$490M milestone payments Constructing PIC/s GMP Plant Taipei Exchange ONENESS IPO 2016 Founded 2011 2009 2008 Listed on Taiwan Emerging Stock Market 2020 ONENESS launched 2021 Market cap today Completed ON101 Ph3 MRCT in US., China, and Taiwan ~USD 3.4 bn | 4

View entire presentation